TY  - JOUR
AU  - Vazquez-Bourgon, Javier
AU  - Ortiz-Garcia-de-la-Foz, Victor
AU  - Gomez-Revuelta, Marcos
AU  - Mayoral-van-Son, Jacqueline
AU  - Juncal-Ruiz, Maria
AU  - Garrido-Torres, Nathalia
AU  - Crespo-Facorro, Benedicto
PY  - 2022
DO  - 10.1093/ijnp/pyac033
UR  - http://hdl.handle.net/10668/19803
T2  - The international journal of neuropsychopharmacology
AB  - Aripiprazole and risperidone are 2 of the most used second-generation antipsychotics (SGAs) worldwide. Previous evidence shows a similar effect of these SGAs on weight and metabolic changes in the short term. However, a longer period is necessary for...
LA  - en
PB  - Oxford University Press
KW  - Metabolism
KW  - schizophrenia
KW  - second-generation antipsychotic
KW  - treatment-naïve
KW  - weight gain
KW  - Humans
KW  - Aripiprazole
KW  - Risperidone
KW  - Antipsychotic Agents
KW  - Psychoses, Substance-Induced
KW  - Metabolome
KW  - Lipids
KW  - Psychotic Disorders
TI  - Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.
TY  - research article
VL  - 25
ER  -